openPR Logo
Press release

Global Chronic Disease Management Market 2019 Observational Studies By Top Companies Like Allscripts; ScienceSoft USA Corporation; Siemens Healthcare Private Limited

03-10-2020 10:01 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Chronic Disease Management Market

Global Chronic Disease Management Market

Global Chronic Disease Management Market By Disease Type (CVD, Diabetes, Cancer, Asthma, COPD, Arthritis, Stroke, Others), Service Type (Consulting Service, Implementation Service, Educational Services, Others), Deployment Model (On-Premise, Cloud-Based, Web-Based), End-User (Provider, Payer, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends & Forecast to 2026

Market Analysis:

Global chronic disease management market is expected to rise to an estimated value of USD 14.80 billion by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing levels of geriatric population resulting in higher prevalence of chronic diseases in patients globally along with the advancement in technologies associated with medical devices.

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-chronic-disease-management-market

Competitive Analysis: Global Chronic Disease Management Market

Global chronic disease management market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of chronic disease management market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Chronic Disease Management Market

Few of the major competitors currently working in the global chronic disease management market are Allscripts; ScienceSoft USA Corporation; Siemens Healthcare Private Limited; EXL; cliexa, Inc.; MINES & Associates, Inc.; Mediware Information Systems; Pegasystems Inc.; HealthCare atHOME; Cognizant TriZetto Software Group, Inc.; IBM Corporation; Infosys Limited; Koninklijke Philips N.V.; AxisPoint Health; Medecision; i2i Systems; Epic Systems Corporation and ZeOmega.

Market Definition: Global Chronic Disease Management Market

Chronic disease management is digital healthcare services that include in providing healthcare officials with educational insights to their patients, implementation of patient-specific and disease-specific treatment options and plans. These services are specifically designed for managing the chronic diseases and reducing their severity in patients.

Market Drivers

Increasing prevalence and awareness regarding the fatality of chronic diseases; this factor is expected to drive the growth of the market
Increasing levels of integration of digitalization in healthcare systems and facilities; this factor is expected to drive the growth of the market
Rise in the support provided by the governments for the adoption of technologies in healthcare management; this factor is expected to drive the market growth
lobal Chronic Disease Management MarketMarket Restraints

Restraint in adoption and obedience in following the treatment plants designed according to the need of their disease management; this factor is expected to restrain the growth of the market
Lack of technically skilled professionals and workforce required for the management and maintenance of these diseases; this factor is expected to restrain the market growth
Grab Your Report at an Impressive 30% Discount! Please click Here@

https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-chronic-disease-management-market

Segmentation: Global Chronic Disease Management Market

By Disease Type

Cardiovascular Diseases (CVD)
Diabetes
Cancer
Asthma
Chronic Obstructive Pulmonary Disorders (COPD)
Arthritis
Stroke
Others
By Service Type

Consulting Service
Implementation Service
Educational Services
Others
By Deployment Model

On-Premise
Cloud-Based
Web-Based
By End-User

Providers
Ambulatory Care Centers
Hospitals, Physician Groups & Integrated Delivery
Diagnostic & Imaging Centers
Home Healthcare Agencies, Nursing Homes & Assisted Living Facilities
Others
Payer
Public Payers
Private Payers
Others
By Geography

Key Developments in the Market:

In October 2018, cliexa, Inc. announced that they had acquired Preventive Technology Solutions Inc. (PTSI). This acquisition will help in the development and expansion of cliexa's service offerings. cliexa, Inc. will focus on the development of health apps for primary care and family medicine physicians which are determining the risks in adolescent for sexual activities, abuse of substances and other issues.
In July 2016, HealthCare at home announced that they had acquired Health Impetus Pvt. Ltd, this acquisition is expected to provide HealthCare at home in providing disease management services as well as providing various services to the pharmaceutical industry.

Reasons to Purchase this Report

Current and future of global chronic disease management market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Chronic Disease Management Market 2019 Observational Studies By Top Companies Like Allscripts; ScienceSoft USA Corporation; Siemens Healthcare Private Limited here

News-ID: 1960623 • Views:

More Releases from Data Bridge Market Research

Water Treatment System Market: Sustaining the Future of Clean Water
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction Understanding Water Treatment Systems Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use. Importance in Global Sustainability Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and